📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. (2018)

First Author: Dakir El-H

Attributed to: Gene-expression connectivity mapping and its application in phenotypic targeting funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.26175

PubMed Identifier: 30405882

Publication URI: http://europepmc.org/abstract/MED/30405882

Type: Journal Article/Review

Volume: 9

Parent Publication: Oncotarget

Issue: 79

ISSN: 1949-2553